Increased Left Atrial Stiffness is Significantly Associated with Paroxysmal Atrial Fibrillation in Diabetic Patients

References

• Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139:e56–e528. doi:10.1161/CIR.0000000000000659
   PubMed Web of Science ®Google Scholar
• Staerk L, Wang B, Preis SR, et al. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 2018;1453:1–10.
   Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;37:2893–2962.
   Google Scholar
• Movahed MR, Hashemzadeh M, Jamal MM, et al. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005;105:315–318. doi:10.1016/j.ijcard.2005.02.050
   PubMed Web of Science ®Google Scholar
• Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332:73–78. doi:10.1136/bmj.38678.389583.7C
   PubMed Web of Science ®Google Scholar
• Ostgren CJ, Merlo J, Rastam LLindblad L, Lindblad U. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes Obes Metab. 2004;6(5):367–374. doi:10.1111/j.1462-8902.2004.00358.x
   PubMed Web of Science ®Google Scholar
• Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J Intern Med. 2001;250(5):382–389. doi:10.1046/j.1365-2796.2001.00902.x
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. Framingham Heart Study. JAMA. 1994;271:840–844. doi:10.1001/jama.1994.03510350050036
   PubMed Web of Science ®Google Scholar
• Aune D, Feng T, Schlesinger S, et al. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. J Diabetes Complications. 2018;32(5):501–511. doi:10.1016/j.jdiacomp.2018.02.004
   PubMed Web of Science ®Google Scholar
• Lane DA, Lip GY. Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation. 2012;126:860–865. doi:10.1161/CIRCULATIONAHA.111.060061
   PubMed Web of Science ®Google Scholar
• Kamel H, Bartz TM, Longstreth WT, et al. Cardiac mechanics and incident ischemic stroke: the cardiovascular health study. Sci Rep. 2021;11:17358. doi:10.1038/s41598-021-96702-z
   PubMed Web of Science ®Google Scholar
• Fatema K, Barnes ME, Bailey KR, et al. Minimum vs. maximum left atrial volume for prediction of first atrial fibrillation or flutter in an elderly cohort: a prospective study. Eur J Echocardiogr. 2009;10:282–286. doi:10.1093/ejechocard/jen235
   PubMed Web of Science ®Google Scholar
• Pagola J, González-Alujas T, Flores A, et al. Left atria strain is a surrogate marker for detection of atrial fibrillation in cryptogenic strokes. Stroke. 2014;45:e164–e166. doi:10.1161/STROKEAHA.114.005540
   PubMed Web of Science ®Google Scholar
• Olsen FJ, Jørgensen PG, Møgelvang R, et al. Predicting paroxysmal atrial fibrillation in cerebrovascular ischemia using tissue Doppler imaging and speckle tracking echocardiography. J Stroke Cerebrovasc Dis. 2016;25:350–359. doi:10.1016/j.jstrokecerebrovasdis.2015.10.004
   PubMed Web of Science ®Google Scholar
• Ble M, Benito B, Cuadrado-Godia E, et al. Left atrium assessment by speckle tracking echocardiography in cryptogenic stroke: seeking silent atrial fibrillation. J Clin Med. 2021;10:3501–3511. doi:10.3390/jcm10163501
   PubMed Web of Science ®Google Scholar
• Arnăutu SF, Morariu VI, Arnăutu DA, et al. Left atrial strain helps identifying the cardioembolic risk in transient ischemic attacks patients with silent paroxysmal atrial fibrillation. Ther Clin Risk Manag. 2022;Volume 18:213–222. doi:10.2147/TCRM.S359490
   Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres G, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery. Eur Heart J. 2020;2020:1–125.
   Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world- wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23:469–480. doi:10.1111/j.1464-5491.2006.01858.x
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;2018:1–98.
   Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging European. Eur Heart J Cardiovasc Imaging. 2015;16:233–271. doi:10.1093/ehjci/jev014
   PubMed Web of Science ®Google Scholar
• Fabiani I, Pugliese NR, Santini V, et al. Speckle-tracking imaging, principles and clinical applications: a review for clinical cardiologists. In: Lakshmanadoss U, editor. Echocardiography in Heart Failure and Cardiac Electrophysiology [Internet]. London: IntechOpen; 2016. Available from: https://www.intechopen.com/chapters/51931. Accessed July 7, 2023.
   Google Scholar
• Cottrell C, Kirkpatrick JN. Echocardiographic strain imaging and its use in the clinical setting. Expert Rev Cardiovasc Ther. 2010;8(1):93–102. doi:10.1586/erc.09.165
   PubMedGoogle Scholar
• Friberg J, Buch P, Scharling H, et al. Rising rates of hospital admissions for atrial fibrillation. Epidemiology. 2003;14(6):666–672. doi:10.1097/01.ede.0000091649.26364.c0
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation, developed in collaboration with EACTS, ESC, EHRA of the ESC. Europ Heart J. 2021;42:373–498.
   PubMed Web of Science ®Google Scholar
• Li S, Wang J, Zhang B, et al. Diabetes mellitus and cause-specific mortality: a population-based study. Diabetes Metab J. 2019;43(3):319–341. doi:10.4093/dmj.2018.0060
   PubMed Web of Science ®Google Scholar
• Tan Y, Zhang Z, Zheng C, et al. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17(9):585–607. doi:10.1038/s41569-020-0339-2
   PubMed Web of Science ®Google Scholar
• Gherasim L, Gherasim M. Association of atrial fibrillation with diabetes mellitus, high risk comorbidities. Mædica. 2022;17:143–152. doi:10.26574/maedica.2022.17.1.143
   PubMedGoogle Scholar
• Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut. 2020;69:1691–1705. doi:10.1136/gutjnl-2020-320622
   PubMed Web of Science ®Google Scholar
• Kassan M, Choi SK, Galán M, et al. Enhanced NF-kB activity impairs vascular function through PARP- 1-, SP- 1-, and COX-2-dependent mechanisms in type 2 diabetes. Diabetes. 2013;62:2078–2087. doi:10.2337/db12-1374
   PubMed Web of Science ®Google Scholar
• Bohne LJ, Johnson D, Rose RA, et al. The association between diabetes mellitus and atrial fibrillation: clinical and mechanistic insights. Front Physiol. 2019;10:135–147.
   PubMed Web of Science ®Google Scholar
• Kosmala W, Sanders P, Marwick TH. Subclinical myocardial impairment in metabolic diseases. JACC Cardiovasc Imaging. 2017;10(6):692–703. doi:10.1016/j.jcmg.2017.04.001
   PubMedGoogle Scholar
• Sonaglioni A, Barlocci E, Adda G, et al. The impact of short-term hyperglycemia and obesity on biventricular and biatrial myocardial function assessed by speckle tracking echocardiography in a population of women with gestational diabetes mellitus. Nutr Metab Cardiovasc Dis. 2022;32(2):456–468. doi:10.1016/j.numecd.2021.10.011
   PubMed Web of Science ®Google Scholar
• Cameli M, Mandoli GE, Loiacono F, et al. Left atrial strain: a new parameter for assessment of left ventricular filling pressure. Heart Fail Rev. 2016;21(1):65–76. doi:10.1007/s10741-015-9520-9
   PubMed Web of Science ®Google Scholar
• Khurram IM, Maqbool F, Berger RD, et al. Association between left atrial stiffness index and atrial fibrillation recurrence in patients undergoing left atrial ablation. Circ Arrhythm Electrophysiol. 2016;9(3):e003163. doi:10.1161/CIRCEP.115.003163
   PubMed Web of Science ®Google Scholar
• Bytyçi I, D’Agostino A, Bajraktari G, et al. Left atrial stiffness predicts cardiac events in patients with heart failure and reduced ejection fraction: the impact of diabetes. Circ Arrhythm Electrophysiol. 2016;9:e003163.
   PubMedGoogle Scholar
• Bytyçi I, Dini FL, Bajraktari A, et al. Speckle tracking-derived left atrial stiffness predicts clinical outcome in heart failure patients with reduced to mid-range ejection fraction. J Clin Med. 2020;9:1244–1252. doi:10.3390/jcm9051244
   PubMed Web of Science ®Google Scholar